Participants
Melanie Solomon; IR Contact Officer; Fulgent Genetics Inc
Ming Hsieh; Chairman of the Board, Chief Executive Officer; Fulgent Genetics Inc
Brandon Perthuis; Chief Commercial Officer; Fulgent Genetics Inc
Paul Kim; Chief Financial Officer; Fulgent Genetics Inc
David Westenberg; Analyst; Piper Sandler Companies
Lu Li; Analyst; UBS
Andrew Cooper; Analyst; Raymond James
Presentation
Operator
Greetings, and welcome to the Fulgent Genetics Q4 2024 conference call and webcast. (Operator Instructions)
As a reminder, this conference is being recorded. It's now my pleasure to turn over to your host Melanie Solomon, Investor Relations.